Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about age/related macular degeneration

Recent news which mentions age/related macular degeneration

Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
Tickers OPT
Tags Health Care General Biotech
From Benzinga
Viteyes Focuses on Eye Health Nutrition during Age-Related Macular Degeneration (AMD) Awareness Month
Tickers AMD
Tags United States Health AMD Month
From PRLog
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
Tickers RHHBF RHHBY RHHVF
Tags Age/Related Macular Degeneration FDA Benzinga
From Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags Benzinga Age/Related Macular Degeneration Penny Stocks
From Benzinga
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Tickers LCTX RHHBF RHHBY RHHVF
Tags News why it's moving Briefs
From Benzinga
Eyecheck Sets Scientific Standard for Premium Ocular Health Supplements
Tickers AMD
Tags Supplements Health and Nutrition Health & Fitness
From PRUnderground
Why Are EyePoint Shares Trading Higher Today?
Tickers EYPT
Tags Phase 1 Trial Small Cap Biotech
From Benzinga
Why Did Mizuho Upgrade This Biotech Stock Focused On Age-Related Eye Diseases?
Tickers UBX
Tags UBX Diabetic Macular Edema Movers
From Benzinga
4D Molecular To Test Its Wet AMD Gene Therapy In Patients
Tickers FDMT
Tags Biotech Small Cap gene therapy
From Benzinga
Unity Biotechnology Stock Falls After Updated Data From Wet AMD Candidate
Tickers UBX
Tags Health Care Phase 1 Trial Biotech
From Benzinga
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
Tickers GRAY REGN
Tags Phase 2 Trial GRAY Market News
From Benzinga
AbbVie, RegenXBio Ink $1.75B Retinal Gene Therapy Collaboration
Tickers ABBV RGNX
Tags Contracts gene therapy Small Cap
From Benzinga
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
Tickers BAYRY BAYZF REGN
Tags Biotech REGN Health Care
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.